# A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma

> clinical trial · VERIFIED · 2026-07-20

Status: ACTIVE_NOT_RECRUITING · Sponsor: Beijing Gene Key Life Technology Co., Ltd · Condition: Hepatocellular Carcinoma (HCC)

- Company: Beijing Gene Key Life Technology Co., Ltd
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07713290

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.